Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2005
10/06/2005WO2005092066A2 Imidazole compounds
10/06/2005WO2005074929A3 Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole
10/06/2005WO2005073216A3 Hcv ns-3 serine protease inhibitors
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222412 Antibiotic; bactericides
10/06/2005US20050222410 Inhibitors of histone deacetylase
10/06/2005US20050222255 Process for producing trans-4-amino-1-cyclohexanecarboxilic acid derivative
10/06/2005US20050222237 Inhibitors of glycogen synthase kinase-3 (GSK-3), a serine/threonine protein kinase; for treatment and prevention of diabetes and Alzheimer's disease
10/06/2005US20050222236 Viral polymerase inhibitors
10/06/2005US20050222230 3,4-diarylpyrazoles and their use in the therapy of cancer
10/06/2005US20050222222 1-[3-[2-[2-cyano-(S)-pyrrolidin-1-yl]-2-oxo-ethylamino]-1-oxo-propyl]-4-[bis-(4-fluorophenyl)methyl]piperazine; inhibiting dipeptidyl peptidase IV or for treating Type II diabetes
10/06/2005US20050222217 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags
10/06/2005US20050222210 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
10/06/2005US20050222207 Phosphodiesterase 4 inhibitors, including N-substituted diarylamine analogs
10/06/2005US20050222206 Pyridinoylpiperidines as 5-ht1f agonists
10/06/2005US20050222203 Nitrogen heterocycle biaryls for osteoporosis and other diseases
10/06/2005US20050222202 Free of N-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone; prepared by reacting 6-hydroxy-3,4-dihydroquinolin-2(1H)-one with 5-(4-chlorobutyl)-1-cyclohexyl-1H-tetrazole; is at least 99% pure
10/06/2005US20050222201 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
10/06/2005US20050222200 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/06/2005US20050222199 Process for the preparation of a hydrate of an antranilic acid derivative
10/06/2005US20050222194 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction
10/06/2005US20050222190 1,4-bis-N-oxide azaanthracenediones and the use thereof
10/06/2005US20050222186 Substituted diaminopyrimidines
10/06/2005US20050222182 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
10/06/2005US20050222167 Amidation of 3-(acidinylamino)-5-methylolanilines with 5-[4-phenylpiperazin-1-yl(thio)carbonylamino]nicotinic acids and the product, which have antitumor activity and low toxicity.
10/06/2005US20050222161 Antagonists to melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient
10/06/2005US20050222159 2,3-dihydropyridazin-3-ones e.g. 3-amino-6-(1-isopropyl-6-oxo-1,6-dihydro-3-pyridazinyl)-5-phenyl-2-pyrazinecarboxamide; adenosine antagonists; depression, dementia, Parkinson's disease, anxiety, pain, hypertension, obesity, gout, bronchial asthma
10/06/2005US20050222155 Inhibitors of akt activity
10/06/2005US20050222152 Enzyme inhibitors for disease treatment with Cathepsin s
10/06/2005US20050222150 6-(p-morpholinoanilino)-4-(4-substituted-1-piperazinyl)-2-(methylthio)pyrimidines having an excellent inhibitory effect on replication of Hepatitis C virus
10/06/2005US20050222141 N-(2,6-dichlorobenzoyl)-4-[1-methyl-7-(pyrrolidine-1-ylmethyl)-2,4-quinazoline-dione-3-yl]-L-phenylalanine trifluoroacetate; 4 integrin antagonist; antiinflammatory, anticarcinogenic agent, antiallergent; asthma, psoriasis, cardiovascular diseases, arterial sclerosis, restenosis, tumor proliferation
10/06/2005US20050222140 Improved DP-IV inhibitors increase the steady state concentrations of GLP-1 and GIP, resulting in improved glucose tolerance
10/06/2005US20050222139 Non-peptide gnrh antagonists
10/06/2005US20050222137 Combination of organic compounds
10/06/2005US20050222124 Benzenesulfonamide derivatives as antipsychotic agents
10/06/2005US20050222118 For therapy of inflammatory or allergic condition
10/06/2005US20050222047 Compounds as enzyme inhibitors to treat hepatitis with viricides
10/06/2005US20050221990 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
10/06/2005US20050221390 High quantum yield acridinium compounds and their uses in improving assay sensitivity
10/06/2005US20050221124 Fluorene-based compound and organic electroluminescent display device using the same
10/06/2005US20050220784 Quinazoline derivatives as medicaments
10/06/2005DE102004012901A1 Silylierte Carboxamide Silylated carboxamides
10/06/2005CA2563164A1 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
10/06/2005CA2561488A1 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonists
10/06/2005CA2561066A1 Antiviral 4-aminocarbonylamino-substituted imidazole compounds
10/06/2005CA2560896A1 Imidazole compounds
10/06/2005CA2560700A1 Tetrahydrocarbazoles and derivatives
10/06/2005CA2559733A1 Inhibitors of histone deacetylase
10/06/2005CA2558889A1 Selected cgrp antagonists, methods for the production thereof and their use as medicaments
10/05/2005EP1582519A2 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/05/2005EP1582516A1 Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same
10/05/2005EP1582211A1 Jnk inhibitor
10/05/2005EP1581527A2 Thrombopoietin mimetics
10/05/2005EP1581523A1 PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
10/05/2005EP1581518A2 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
10/05/2005EP1581517A1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
10/05/2005EP1581516A2 3-heterocyclic benzylamide derivatives as potassium channel openers
10/05/2005EP1581515A1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/05/2005EP1581514A2 Chemical compounds
10/05/2005EP1581505A1 Pyridazinone derivatives as gsk-3beta inhibitors
10/05/2005EP1581503A2 Ophthalmic compositions for treating ocular hypertension
10/05/2005EP1581501A1 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as caspase inhibitors
10/05/2005EP1581499A1 Microsomal triglyceride transfer protein inhibitors
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581494A2 Piperidine derivatives useful as ccr5 antagonists
10/05/2005EP1581493A1 Factor xa inhibitors
10/05/2005EP1581492A1 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
10/05/2005EP1581488A1 Inhibitors of tace
10/05/2005EP1581309A2 Kinase modulators
10/05/2005EP1581261A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands
10/05/2005EP1581232A1 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases
10/05/2005EP1581229A1 Phthalazine derivatives as phosphodiesterase 4 inhibitors
10/05/2005EP1581222A2 COMPOSITIONS AND METHODS FOR INHIBITING TGF-&bgr;
10/05/2005EP1202733B1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005EP1156039B1 Pyridazin-3-one derivatives and medicines containing the same
10/05/2005CN1678613A Hetereoaryl nitrile derivatives
10/05/2005CN1678608A New neuropeptide y y5 receptor antagonists
10/05/2005CN1678607A Nitrogen-containing aromatic ring derivatives
10/05/2005CN1678606A Novel crystals
10/05/2005CN1678605A Synthesis of 4-(piperidyl)(2-pyridy)methanone-(e)-o-methyloxime and its salts
10/05/2005CN1678604A Novel benzoimidazole derivatives useful as antiproliferative agents
10/05/2005CN1678593A Microbiocidal (e.g. fungicidal) 1, 2, 3-triazole derivatives
10/05/2005CN1678591A New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
10/05/2005CN1678590A Amide derivative and medicine
10/05/2005CN1678589A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them
10/05/2005CN1678587A CCK-1 receptor modulators
10/05/2005CN1678586A 取代的喹啉ccr5受体拮抗剂 Substituted quinoline ccr5 receptor antagonist
10/05/2005CN1678585A Therapeutic agents useful for treating pain
10/05/2005CN1678578A Indoles having anti-diabetic activity
10/05/2005CN1678573A Diarylurea derivatives and their use as chloride channel blockers
10/05/2005CN1678320A N-biarylmethyl aminocycloalkanecarboxamide derivatives
10/05/2005CN1678317A 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/05/2005CN1678315A Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
10/05/2005CN1678307A Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors
10/05/2005CN1678306A -3 (sulfonamidoethyl) -indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
10/05/2005CN1678192A Arthropodicidal anthranilamides
10/05/2005CN1221546C Diphenyl azetidinone derivatives, method for prodn. thereof, medicaments contg. these compounds, and their use
10/05/2005CN1221545C Method for producing 4-(heteroaryl-methyl)-halogen-1 (2H)-2, 3-phthalazones
10/05/2005CN1221544C Pyrazole cyclic AMP-specific PDE inhibitors
1 ... 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 ... 1080